Quest Diagnostics Inc Financial and Nonfinancial Liabilities, Fair Value Disclosure
Quest Diagnostics Inc (DGX) had Financial and Nonfinancial Liabilities, Fair Value Disclosure of $291.00 million as of 2026-06-30, per its 10-Q filed 2026-07-23.
Financial Statements › Notes › Fair Value Disclosures › Fair Value, Net Asset (Liability)
us-gaap:LiabilitiesFairValueDisclosure · last filed 2026-07-23
- 2026-06-30: Financial and Nonfinancial Liabilities, Fair Value Disclosure $291.00M.
- 2026-03-31: Financial and Nonfinancial Liabilities, Fair Value Disclosure $253.00M.
- 2025-12-31: Financial and Nonfinancial Liabilities, Fair Value Disclosure $246.00M.
| Period end | Financial and Nonfinancial Liabilities, Fair Value Disclosure |
|---|---|
| 2026-06-30 | $291.00M 10-Q · filed 2026-07-23 |
| 2026-03-31 | $253.00M 10-Q · filed 2026-04-22 |
| 2025-12-31 | $246.00M 10-Q · filed 2026-07-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LABCORP HOLDINGS INC. (LH) | United States | $25.060B | 22.60 |
| Guardant Health, Inc. (GH) | United States | $23.675B | -12.65 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |